StockData
Nkarta, Inc. logo

Nkarta, Inc. (NKTX) stock

NKTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30
$1.25+0.04 (+3.31%)

Close on Nov 17, 2026Market cap $89.53MP/E –Yield 0.00%

Nkarta EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Nkarta's EPS for the twelve months ending Jun 30, 2026 was -$1.57. For fiscal 2025 it was -$1.41. The highest annual figure on record is -$1.41 in fiscal 2025.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$1.41–
FY2024Dec 31, 2024-$1.60–
FY2023Dec 31, 2023-$2.40–
FY2022Dec 31, 2022-$2.61–
FY2021Dec 31, 2021-$2.62–
FY2020Dec 31, 2020-$5.44–
FY2019Dec 31, 2019-$14.41–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$0.54–
Q1 FY2026Mar 31, 2026-$0.37–
Q4 FY2025Dec 31, 2025-$0.37–
Q3 FY2025Sep 30, 2025-$0.29–
Q2 FY2025Jun 30, 2025-$0.31–
Q1 FY2025Mar 31, 2025-$0.43–
Q4 FY2024Dec 31, 2024-$0.35–
Q3 FY2024Sep 30, 2024-$0.39–
Q2 FY2024Jun 30, 2024-$0.34–
Q1 FY2024Mar 31, 2024-$0.58–
Q4 FY2023Dec 31, 2023-$0.57–
Q3 FY2023Sep 30, 2023-$0.52–
Q2 FY2023Jun 30, 2023-$0.68–
Q1 FY2023Mar 31, 2023-$0.63–
Q4 FY2022Dec 31, 2022-$0.67–
Q3 FY2022Sep 30, 2022-$0.58–
Q2 FY2022Jun 30, 2022-$0.61–
Q1 FY2022Mar 31, 2022-$0.79–
Q4 FY2021Dec 31, 2021-$0.69–
Q3 FY2021Sep 30, 2021-$0.68–
Q2 FY2021Jun 30, 2021-$0.66–
Q1 FY2021Mar 31, 2021-$0.59–
Q3 FY2020Sep 30, 2020-$0.44–
Q2 FY2020Jun 30, 2020-$30.06–
Q1 FY2020Mar 31, 2020-$5.41–
Q4 FY2019Dec 31, 2019-$6.62–
Q3 FY2019Sep 30, 2019-$1.75–
Q2 FY2019Jun 30, 2019-$3.39–

More Nkarta figures

See a number that looks wrong?